Search This Blog

Tuesday, December 12, 2023

Regeneron Pharmaceuticals, Inc.: Morgan Stanley raises the target price from USD 914 to USD 941.

  maintains its overweight rating 

https://www.marketscreener.com/quote/stock/REGENERON-PHARMACEUTICALS-10649/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)